Your session is about to expire
← Back to Search
SMS Text Messaging for Urinary Dysfunction in Children (Text4US Trial)
N/A
Waitlist Available
Led By Kathleen Kan, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Text4US Trial Summary
This trial will test a text message-based healthcare assistant to help children with pLUTS and their families improve bladder behaviors for better quality of life.
Who is the study for?
This trial is for English-speaking parents or guardians over 18 with children aged 5-18 who have urinary issues but no major genitourinary abnormalities, neurogenic bladder, recent surgeries, immunosuppression, or other chronic illnesses affecting the urinary tract. Participants must be able to text and not have used a bladder/food diary before.Check my eligibility
What is being tested?
The study tests a text message-based healthcare assistant designed to help manage pediatric Lower Urinary Tract Symptoms (pLUTS). It aims to see if texting can effectively support parents in guiding their children towards healthy bladder behaviors.See study design
What are the potential side effects?
Since this intervention involves SMS text messaging as a reminder system for behavior change rather than medication or invasive procedures, there are no direct medical side effects. However, increased screen time or potential stress from frequent reminders could occur.
Text4US Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Effectiveness of the Text4US program
Feasibility of Text-Messaging System
Usefulness and Acceptability of the Text4US program
Text4US Trial Design
2Treatment groups
Experimental Treatment
Group I: Group 2: SMS - DiariesExperimental Treatment1 Intervention
Group 2 will receive SMS Text reminders during the first 2 weeks of the study, and then will be asked to complete a 2-day bladder diary + food diary during the last two weeks of the study.
Both groups will complete a pre-survey at the beginning of the study and a post-survey after each phase of the study (total 2 post-surveys).
Group II: Group 1: Diaries - SMSExperimental Treatment1 Intervention
Group 1 will be asked to complete a 2-day bladder diary + food diary during the first two weeks of the study, then will receive SMS Text reminders during the last 2 weeks of the study.
Both groups will complete a pre-survey at the beginning of the study and a post-survey after each phase of the study (total 2 post-surveys).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SMS Text Messaging
2018
N/A
~770
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,390 Previous Clinical Trials
17,340,725 Total Patients Enrolled
Kathleen Kan, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
205 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent/guardian of a child under 5 or over 18.My child had surgery on their belly or back within the last year.My child has had or is going to have a kidney transplant.I am under 18 years old.I am not fluent in English.I am a parent of a child aged 5-18 who has completed potty training and has lower urinary tract symptoms.I have been diagnosed with lower urinary tract symptoms.My child has been diagnosed with Detrusor sphincter dyssynergia.My child has a chronic illness that affects their bladder or urinary system.My child has a urinary or genital condition.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1: Diaries - SMS
- Group 2: Group 2: SMS - Diaries
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies for participants in this research trial?
"According to the clinicaltrials.gov page, this particular medical trial is no longer in pursuit of candidates for enrollment. Initially posted on November 17th 2022 and last updated August 7th 2023; nonetheless, there are two other studies that have open recruitment at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger